Regulation - Healthcare, Biotechnology

Filter

Current filters:

HealthcareBiotechnology

Popular Filters

New EULAR recommendations address use of synthetic and biological DMARDs

05-07-2013

The European League Against Rheumatism (EULAR) has this week released updated recommendations for the…

ActemraBiotechnologyBristol-Myers SquibbEuropeHealthcareMabTheraOrenciaPfizerPharmaceuticalRegulationRocheXeljanz

Increased focus on generics and biosimilars only way to make European health care sustainable, says EGA

13-06-2013

Addressing delegates at the 19th European Generic medicines Association (EGA) Annual Conference in Athens,…

BiotechnologyEuropeFinancialGenericsHealthcareRegulation

MoCA report a welcome stepping stone, but access to orphan medicines remains unfinished business, say trade groups

09-05-2013

The three leading pharma/biotech trade bodies, EuropaBio, the European Federation of Pharmaceutical Industries…

BiotechnologyEuropeHealthcarePharmaceuticalPoliticsRare diseasesRegulation

Progress on better access to medicines for patients in Europe

19-04-2013

Significant progress was made in the work of the Process on Corporate Responsibility in the field of…

BiotechnologyEuropeHealthcarePharmaceuticalPricingRegulation

Experimental data published on use of recommended medicines and treatments by UK's NHS

10-01-2013

Experimental data about the use of the UK drug watchdog the National Institute for Health and Clinical…

BiotechnologyEuropeHealthcarePharmaceuticalRegulation

EMA starts consultation on children's medicines with cadiovasculars

02-09-2012

The European Medicines Agency has begun its first public consultation on its inventory of medicines for…

BiotechnologyCardio-vascularEuropeHealthcarePharmaceuticalRegulation

US health care reform looks to squeeze players up and down the value chain

09-08-2012

This summer's landmark Supreme Court decision to uphold the USA's Patient Privacy and Affordable Care…

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalRegulationResearch

US patients get faster access to more cancer drugs than Europeans, says Tufts

11-07-2012

Cancer patients in the USA get faster access to more oncology drugs to treat their disease than patients…

BiotechnologyEuropeHealthcareNorth AmericaOncologyPharmaceuticalPricingRegulation

Health Canada received nearly 42 thousand domestic AR reports in 2011

11-07-2012

In 2011, the medical industry regulatory Health Canada received 41,923 domestic drug adverse reaction…

BiotechnologyHealthcareNorth AmericaPharmaceuticalRegulation

Australian patients to benefit from new PBS listings; OTC reforms

26-06-2012

The listing of 11 prescription medicines on the Australian Pharmaceutical Benefits Scheme (PBS) has been…

Asia-PacificBiotechnologyHealthcarePharmaceuticalPricingRegulation

Recalls threaten public confidence in vaccines and immunoglobulins

27-03-2012

Quality defects and donor tissue history must be more carefully monitored to increase public acceptance…

BiotechnologyHealthcareImmunologicalsRegulationVaccines

Burden of USA CMS rules on outpatient drugs

02-02-2012

Burden of USA CMS rules on outpatient drugs

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalRegulation

PCMA outlines $100 billion in Rx drug savings in USA

01-09-2011

As the USA’s Joint Select Committee on Deficit Reduction examines options to reduce the deficit…

BiotechnologyGenericsHealthcareNorth AmericaPharmaceuticalPricingRegulation

Back to top